Hebrew U Neurobiologist wins Blumberg prize for Parkinson's work

Previous JNF_KKL administered award recipient went on to win Nobel Prize.

May 11, 2017 12:44
2 minute read.

Blumberg Prize Awarded to Hebrew U Professor of Neurobiology. (photo credit: KKL-JNF)

Professor Hagai Bergman of the Department of Neurobiology at the Hebrew University is the recipient of the third Dr. Otto and Alice Blumberg Prize, which is administered by JNF KKL Germany, for his outstanding research in the computational physiology of the basal ganglia and their disorders, namely Parkinson's disease and schizophrenia using deep brain stimulation procedures.

Bergman was awarded the prize in a festive May 7 ceremony at the Hebrew University School of Medicine in the presence of family, friends, and a delegation from
JNF-KKL Germany.

“Keren Kayemeth LeIsrael is privileged to award the Dr. Otto and Alice Blumberg Prize this year to Professor Hagai Bergman. This significant prize is part of the various scholarships and prizes we award for excellence in research and education,” said JNF-KKL Germany President Sarah Singer, who presented the award to Bergman. “Through our prizes we contribute to the success of the State of Israel in all fields, including science and technology.”

Singer was accompanied at the ceremony by the delegation of JNF-KKL Germany members, who were also spending several days touring Israel and learning about the activities KKL-JNF engages in throughout the country. KKL-JNF Scholarships Coordinator Rivka Rei and JNF-KKL Germany representative Zipi Roitman also attended the ceremony.

The Blumberg Prize was originally known as the Samuel and Paula Elkeles Prize. For 25 years, it had been awarded top Israeli scientists including Professor Aharon Ciechanover, who later went on to receive the Noble Prize in Chemistry. The prize was
revived three years ago by Alice Blumberg of Germany, in memory of her late husband, Dr. Otto Blumberg.

“Professor Bergman has directed ground breaking scientific research over the last three decades in the field of neurodegenerative conditions. He has demonstrated for the first time that the sub thalamic nucleus, which is a structure in the brain, is an optimal target for improvement of the motor symptoms of Parkinson’s disease,” said Dr. Yahaloma Gat, Senior Scientific Director of the Chief Scientist Office of the Israeli Ministry of Health.


Read more about the Blumberg Prize ceremony


Related Content